NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations

Satya Narayan(University of Florida Health), Robert Hromas(The University of Texas at San Antonio Health Science Center)
Oncotarget
August 1, 2017
Cited by 17


Related Papers